Overall and disease-free survival greater than 12 years in metastatic non-small cell lung cancer after linear accelerator-based stereotactic radiosurgery for solitary brain metastasis

Marta Scorsetti, Filippo Alongi, Piera Navarria, Diego Cortinovis, Paolo Bidoli

Research output: Contribution to journalArticlepeer-review

Abstract

The best treatment approach for solitary brain metastasis is not well defined and there is no consensus on this issue. It is still being debated whether patients with isolated brain metastasis should undergo surgical resection or stereotactic radiosurgery, and which patients should receive adjuvant whole brain radiotherapy. The median survival in patients with single or multiple metastatic lesions who underwent only stereotactic radiosurgery improved from two-three months to nine months. To the best of our knowledge this is the first report on patients treated with linear accelerator-based stereotactic radiosurgery alone where an overall survival of more than 12 years was obtained, maintaining good quality of life in three cases of solitary brain metastasis from non-small cell lung cancer. In addition to the case reports, we present a brief literature review on this topic.

Original languageEnglish
JournalTumori
Volume98
Issue number2
DOIs
Publication statusPublished - Mar 2012

Keywords

  • Disease-free survival
  • Non-small cell lung cancer
  • Overall survival
  • Radiosurgery
  • Single brain metastasis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Overall and disease-free survival greater than 12 years in metastatic non-small cell lung cancer after linear accelerator-based stereotactic radiosurgery for solitary brain metastasis'. Together they form a unique fingerprint.

Cite this